NIBAN3: A Drug Target / Disease Biomarker (G199786)

Target Name: NIBAN3

NCBI ID: G199786

NIBAN3

NIBAN3: A Drug Target / Disease Biomarker

NIBAN-3 (N-isothiocyanate-insensitive BNP-3) is a protein that is expressed in the brain and is known for its role in the regulation of neurotransmitter release. NIBAN-3 has been shown to play a crucial role in the regulation of the neurotransmitter serotonin, which is involved in a wide range of physiological processes including mood, appetite, and sleep.

Recent studies have suggested that NIBAN-3 may be a drug target or biomarker for various psychiatric and neurological disorders. For example, NIBAN-3 has been shown to be involved in the pathophysiology of major depressive disorder (MDD), and has been shown to play a negative role in the treatment response of MDD.

In addition to its potential therapeutic applications, NIBAN-3 has also been shown to have potential diagnostic implications. For example, NIBAN-3 has been shown to be decreased in individuals with MDD, and has been used as a potential biomarker for this disorder. Additionally, NIBAN-3 has been shown to be decreased in individuals with certain neurological disorders, such as Alzheimer's disease, and has been used as a potential biomarker for these disorders.

The potential drug targets for NIBAN-3 are vast and continue to be explored by researchers. One potential drug that may target NIBAN-3 is a neurotransmitter antagonist, such as a selective serotonin reuptake inhibitor (SSRI). SSRIs are commonly used to treat depression and other psychiatric disorders, and may be effective in treating NIBAN-3-related disorders.

Another potential drug that may target NIBAN-3 is a dopamine agonist, such as a dopamine transporter antagonist (DAT). DATs are commonly used to treat Parkinson's disease and may be effective in treating NIBAN-3-related disorders.

In addition to drug treatments, NIBAN-3 may also be treated with behavioral therapies such as cognitive-behavioral therapy (CBT). CBT is a form of psychotherapy that is commonly used to treat depression and other psychiatric disorders, and may be effective in treating NIBAN-3-related disorders.

Overall, NIBAN-3 is a protein that continues to be an important player in the regulation of neurotransmitter release and the pathophysiology of various psychiatric and neurological disorders. Further research is needed to fully understand the potential therapeutic and diagnostic applications of NIBAN-3, and to develop effective treatments for NIBAN-3-related disorders.

Protein Name: Niban Apoptosis Regulator 3

The "NIBAN3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NIBAN3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets